Cargando…
Sodium–glucose co-transporter 2 inhibitors for the treatment of cardio-renal syndrome
The 2021 guidelines of the European Society of Cardiology on the diagnosis and therapy of heart failure (HF) introduced relevant changes in the pharmacological treatment of chronic HF. Among these, certainly the most significant was the introduction in the therapeutic flow-chart (with the highest re...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653151/ https://www.ncbi.nlm.nih.gov/pubmed/36380781 http://dx.doi.org/10.1093/eurheartjsupp/suac101 |